Stock listing
NASDAQ:NKTR Nektar Therapeutics Stock
Home listing (NASDAQ) of Nektar Therapeutics
Follow Nektar Therapeutics into a list and get an email when it puts out news.
Share price · NASDAQ:NKTR
$38.87 USD -0.31 (-0.8%)
Close on Oct 30, 2026
- Day range
- $38.00 – $39.30 USDOct 30, 2026
- Volume
- 600,420 sharesOct 30, 2026
- Market cap
- $1.33B USDAt the close on Oct 30, 2026 · price × 34.14M shares outstanding
- 52-week range
- $33.40 – $109.00 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $61.04M USDMedian day 756,924 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:NKTR · Home | $38.87 USD | -0.31 (-0.8%) | 600,420 | $38.92 | $39.30 | $38.00 | $39.18 | Close on Oct 30, 2026 |
| LSE:0UNL | $37.74 USD | +0.63 (+1.7%) | 1,162 | $37.52 | $38.42 | $36.80 | $37.11 | Close on Oct 27, 2026 |
| Frankfurt:ITH0 | €34.83 EUR | +1.66 (+5.0%) | — | €34.83 | €34.83 | €34.83 | €33.17 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:NKTR · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $38.87 | -0.31 | -0.8% | $38.92 | $39.30 | $38.00 | 600,420 | |
| $39.18 | +0.63 | +1.6% | $38.35 | $39.89 | $38.35 | 490,175 | |
| $38.55 | +0.58 | +1.5% | $37.49 | $38.60 | $37.49 | 404,793 | |
| $37.97 | +0.52 | +1.4% | $37.52 | $38.40 | $37.05 | 567,772 | |
| $37.45 | +0.23 | +0.6% | $37.18 | $37.92 | $36.94 | 532,570 | |
| $37.22 | -1.43 | -3.7% | $37.87 | $38.16 | $36.67 | 469,600 | |
| $38.65 | +0.38 | +1.0% | $38.01 | $38.80 | $37.00 | 1,019,500 | |
| $38.27 | -0.95 | -2.4% | $39.09 | $40.35 | $38.25 | 619,400 | |
| $39.22 | +2.58 | +7.0% | $36.99 | $39.25 | $36.50 | 1,057,600 | |
| $36.64 | +0.86 | +2.4% | $36.00 | $36.79 | $35.64 | 831,500 | |
| $35.78 | -1.94 | -5.1% | $38.05 | $38.05 | $35.61 | 784,200 | |
| $37.72 | +0.83 | +2.2% | $37.15 | $38.74 | $36.94 | 684,200 | |
| $36.89 | -1.03 | -2.7% | $37.50 | $37.75 | $36.56 | 999,700 | |
| $37.92 | -1.92 | -4.8% | $39.79 | $39.83 | $37.75 | 2,043,900 | |
| $39.84 | -1.33 | -3.2% | $40.93 | $40.98 | $39.26 | 1,048,200 | |
| $41.17 | +0.37 | +0.9% | $40.38 | $42.38 | $40.33 | 1,174,700 | |
| $40.80 | +0.54 | +1.3% | $39.89 | $41.14 | $39.01 | 1,749,500 | |
| $40.26 | +0.35 | +0.9% | $39.22 | $40.35 | $38.45 | 1,510,100 | |
| $39.91 | -2.31 | -5.5% | $42.44 | $42.44 | $39.34 | 1,956,800 | |
| $42.22 | -1.36 | -3.1% | $43.50 | $43.50 | $41.35 | 2,029,300 | |
| $43.58 | -3.41 | -7.3% | $47.09 | $47.13 | $43.51 | 2,919,900 | |
| $46.99 | -13.56 | -22.4% | $55.41 | $56.69 | $46.29 | 6,271,700 | |
| $60.55 | +1.31 | +2.2% | $59.96 | $62.40 | $58.91 | 1,209,700 | |
| $59.24 | -1.16 | -1.9% | $60.14 | $60.75 | $57.69 | 1,815,500 | |
| $60.40 | +3.34 | +5.9% | $57.00 | $61.40 | $56.40 | 1,376,200 | |
| $57.06 | -2.32 | -3.9% | $59.77 | $60.98 | $57.04 | 2,636,100 | |
| $59.38 | +1.72 | +3.0% | $58.03 | $61.79 | $56.21 | 2,798,400 | |
| $57.66 | -3.31 | -5.4% | $60.40 | $61.00 | $56.92 | 1,843,800 | |
| $60.97 | -5.87 | -8.8% | $67.08 | $68.33 | $59.44 | 3,317,500 | |
| $66.84 | -0.26 | -0.4% | $68.53 | $69.84 | $66.71 | 765,900 | |
| $67.10 | -1.26 | -1.8% | $68.00 | $69.09 | $66.98 | 2,806,200 | |
| $68.36 | +0.98 | +1.5% | $67.95 | $69.51 | $67.34 | 1,264,100 | |
| $67.38 | +0.74 | +1.1% | $67.00 | $67.65 | $65.85 | 985,900 | |
| $66.64 | -1.86 | -2.7% | $68.10 | $68.48 | $65.75 | 1,257,600 | |
| $68.50 | -1.26 | -1.8% | $70.00 | $70.00 | $68.03 | 919,800 | |
| $69.76 | -0.89 | -1.3% | $71.41 | $71.41 | $68.35 | 784,100 | |
| $70.65 | -2.67 | -3.6% | $72.01 | $73.50 | $70.60 | 942,200 | |
| $73.32 | -2.12 | -2.8% | $75.10 | $75.63 | $72.00 | 941,900 | |
| $75.44 | +1.25 | +1.7% | $74.10 | $77.76 | $74.00 | 867,100 | |
| $74.19 | -2.18 | -2.9% | $74.67 | $75.63 | $73.64 | 607,300 | |
| $76.37 | +3.63 | +5.0% | $73.41 | $76.63 | $72.99 | 691,300 | |
| $72.74 | +0.99 | +1.4% | $72.38 | $74.72 | $70.70 | 344,800 | |
| $71.75 | +0.37 | +0.5% | $70.41 | $72.73 | $70.00 | 334,100 | |
| $71.38 | -1.14 | -1.6% | $71.42 | $72.18 | $70.00 | 381,500 | |
| $72.52 | -2.03 | -2.7% | $74.01 | $74.84 | $71.20 | 579,700 | |
| $74.55 | +0.78 | +1.1% | $74.00 | $75.33 | $73.19 | 340,300 | |
| $73.77 | -1.19 | -1.6% | $74.21 | $74.97 | $73.61 | 450,200 | |
| $74.96 | +1.27 | +1.7% | $74.98 | $76.79 | $74.06 | 414,906 | |
| $73.69 | -0.33 | -0.4% | $73.01 | $74.40 | $70.93 | 747,947 | |
| $74.02 | -0.51 | -0.7% | $75.10 | $76.23 | $72.83 | 614,100 | |
| $74.53 | -1.55 | -2.0% | $76.08 | $76.53 | $73.19 | 438,600 | |
| $76.08 | +2.44 | +3.3% | $75.00 | $76.22 | $73.43 | 731,800 | |
| $73.64 | +0.97 | +1.3% | $72.00 | $74.91 | $70.48 | 565,500 | |
| $72.67 | -0.35 | -0.5% | $72.09 | $74.80 | $70.51 | 682,600 | |
| $73.02 | -2.90 | -3.8% | $74.00 | $75.75 | $72.05 | 828,400 | |
| $75.92 | -0.11 | -0.1% | $76.40 | $77.22 | $75.45 | 628,200 | |
| $76.03 | +0.53 | +0.7% | $75.99 | $76.74 | $75.42 | 542,800 | |
| $75.50 | +0.64 | +0.9% | $75.59 | $75.67 | $74.02 | 325,900 | |
| $74.86 | -1.62 | -2.1% | $75.52 | $76.43 | $74.33 | 486,900 | |
| $76.48 | +3.03 | +4.1% | $74.55 | $77.00 | $73.18 | 899,000 | |
| $73.45 | +0.36 | +0.5% | $72.66 | $74.19 | $72.41 | 403,500 | |
| $73.09 | +0.33 | +0.5% | $73.56 | $74.23 | $72.00 | 580,900 | |
| $72.76 | +2.17 | +3.1% | $71.00 | $73.09 | $71.00 | 717,900 | |
| $70.59 | -0.08 | -0.1% | $70.72 | $71.00 | $67.11 | 611,800 | |
| $70.67 | -0.78 | -1.1% | $70.84 | $71.43 | $69.50 | 497,200 | |
| $71.45 | +0.77 | +1.1% | $70.02 | $72.79 | $70.02 | 676,800 |
- Ticker
- NASDAQ:NKTR
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 27, 2026
Nektar Therapeutics to Announce Financial Results for the Third Quarter on Thursday, November 12, 2026, After Close of U.S.-Based Financial Markets
Latest earnings call · Aug 13, 2026
Nektar Therapeutics (NASDAQ:NKTR) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Oct 1, 2026
EADV Analyst and Investor Event 2026
Conference · 38 slides
Calls
Upcoming
Nektar Therapeutics (NASDAQ:NKTR) Q3 2026 Earnings Call
Thu, Nov 12, 2026 · 5:00 PM ET
Register
Replays
Nektar Therapeutics (NASDAQ:NKTR) Q2 2026 Earnings Call
Thu, Aug 13, 2026 · 5:00 PM ET
Watch TranscriptNektar Therapeutics (NASDAQ:NKTR) Q1 2026 Earnings Call
Thu, May 07, 2026 · 5:00 PM ET
Watch TranscriptNektar Therapeutics (NASDAQ:NKTR) Q4 2025 Earnings Call
Thu, Mar 12, 2026 · 5:00 PM ET
Watch Transcript
Latest news
Nektar Therapeutics to Announce Financial Results for the Third Quarter on Thursday, November 12, 2026, After Close of U.S.-Based Financial Markets
Oct 27, 2026
Closed $38.55 (+1.5%) on Oct 28, 2026
Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Oct 23, 2026
Closed $37.45 (+0.6%) on Oct 26, 2026
/UPDATE -- Nektar Therapeutics/
Oct 1, 2026
Closed $46.99 (-22.4%) on Oct 1, 2026
New Rezpegaldesleukin Data Supporting Long-term Durability and Disease Improvement in Patients with Alopecia Areata and Atopic Dermatitis at EADV Congress 2026
Oct 1, 2026
Closed $46.99 (-22.4%) on Oct 1, 2026
New Biomarker Data Presented in a Late Breaking Oral Presentation at EADV Congress 2026 Showing Early Molecular Responses to Rezpegaldesleukin Across Multiple Immune Pathways Dysregulated in Patients with Atopic Dermatitis
Sep 30, 2026
Closed $60.55 (+2.2%) on Sep 30, 2026
Nektar Announces Three Oral Presentations for Rezpegaldesleukin at the European Academy of Dermatology & Venereology (EADV) Congress 2026
Sep 28, 2026
Closed $60.40 (+5.9%) on Sep 28, 2026
Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(4)
Aug 31, 2026
Closed $71.38 (-1.6%) on Aug 31, 2026
Nektar Announces Publication in The Lancet of Positive Phase 2b REZOLVE-AD 16-Week Induction Results of Rezpegaldesleukin in Moderate-to-Severe Atopic Dermatitis
Aug 25, 2026
Closed $74.96 (+1.7%) on Aug 25, 2026
Nektar Therapeutics Announces Second Quarter 2026 Financial Results
Aug 13, 2026
Closed $73.02 (-3.8%) on Aug 14, 2026
Decks
EADV Analyst and Investor Event 2026
Conference · 38 slides · Oct 1, 2026
Investor Presentation (September 2026)
Investor deck · 70 slides · September 2026
Investor Presentation (April 2026)
Investor deck · 36 slides · Apr 20, 2026
Technical Presentation (February 2026)
Technical · 37 slides · Feb 10, 2026
Nektar Therapeutics on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 34 in the last 12 months · 189 in all · newest Oct 27, 2026 · oldest 2019
- Calls
- 20 calls with a replay · 20 with a transcript · latest Aug 13, 2026
- Decks
- 18 decks · latest Oct 1, 2026
Where Nektar Therapeutics is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:NKTR · Home listing · This page | NASDAQ | United States | USD |
| gettex:ITH0 | gettex | Germany | EUR |
| LS Exchange:A419UB | LS Exchange | Germany | EUR |
| Tradegate:ITH0 | Tradegate | Germany | EUR |
| Lang & Schwarz:A419UB | Lang & Schwarz | Germany | EUR |
| LSE:0UNL | LSE | United Kingdom | USD |
| BMV:NKTR | BMV | Mexico | MXN |
| BIVA:NKTR | BIVA | Mexico | MXN |
| BOATS:NKTR | BOATS | United States | USD |
| BX Swiss:NKTR | BX Swiss | Switzerland | CHF |
| Dusseldorf:ITH0 | Dusseldorf | Germany | EUR |
| Frankfurt:ITH0 | Frankfurt | Germany | EUR |
| Hamburg:ITH0 | Hamburg | Germany | EUR |
| Munich:ITH0 | Munich | Germany | EUR |
| Stuttgart:ITH0 | Stuttgart | Germany | EUR |
| Hanover:ITH0 | Hanover | Germany | EUR |
| Xetra:ITH0 | Xetra | Germany | EUR |
Log in to ask 6ix AI your own questions about Nektar Therapeutics.